文献速递心脑血管急症重症综合管理与镇静镇痛

SB290157抑制C3a/C3aR通过PKC/P38/NLRP3信号通路减轻脑出血后神经炎症

Inhibition of C3a/C3aR by SB290157 Attenuates Neuroinflammation via PKC/P38/NLRP3 Signaling Pathway After Intracerebral Hemorrhage.
PubMed 文献 · Neurocrit Care · 2025-03-05
一句话结论小鼠脑出血模型中,C3aR拮抗剂SB290157腹腔注射可减轻脑水肿、神经炎症并改善短期和长期神经功能,机制部分依赖C3aR/PKC/P38/NLRP3通路。

该研究在小鼠自体血注入右侧基底节脑出血模型中,于造模后1小时腹腔注射C3aR拮抗剂SB290157,观察其对神经炎症和神经功能的影响及PKC/P38/NLRP3通路的作用。结果显示SB290157改善短期和长期行为学缺陷、减轻脑水肿、减少活化小胶质细胞和中性粒细胞浸润,并下调磷酸化PKC、磷酸化P38、NLRP3及TNF-α、IL-6、IL-1β表达。C3aR siRNA和C3aR内源性激动剂C3a可逆转SB290157的保护作用,选择性激活PKC/P38/NLRP3信号也减弱其抗炎效果。作者认为靶向C3aR抑制NLRP3依赖性神经炎症可能为脑出血治疗提供有前景的途径。

要点

  • 小鼠脑出血模型造模后1小时腹腔注射SB290157,可改善短期和长期行为学缺陷并减轻脑水肿。
  • SB290157减少脑出血后活化小胶质细胞数量和中性粒细胞浸润,下调TNF-α、IL-6、IL-1β表达。
  • SB290157下调磷酸化PKC、磷酸化P38和NLRP3表达,提示经C3aR/PKC/P38/NLRP3通路发挥抗炎作用。
  • C3aR siRNA或C3aR内源性激动剂C3a可逆转SB290157的保护作用。
  • 选择性激活PKC/P38/NLRP3信号可减弱SB290157在脑出血后的抗炎效果。

适用人群与场景

  • CD-1小鼠自体血注入右侧基底节脑出血模型,造模后1小时腹腔注射SB290157。

处置流程与药物剂量

  • 脑出血造模后1小时腹腔注射SB290157;原文未写明剂量、浓度和疗程。

研究设计与关键结果

  • 研究类型为动物实验,共276只CD-1小鼠随机分入不同实验组;脑出血模型经右侧基底节注入自体血构建,SB290157于造模后1小时腹腔注射。
  • C3aR主要表达于小胶质细胞;脑出血后右半球C3a和C3aR表达上调。
  • 腹腔注射SB290157改善脑出血后短期和长期行为学缺陷、减轻脑水肿、减少活化小胶质细胞数量和中性粒细胞浸润,并下调磷酸化PKC、磷酸化P38、NLRP3及TNF-α、IL-6、IL-1β表达。
  • 给予C3aR siRNA和C3aR内源性激动剂C3a可逆转SB290157的保护作用。
  • 选择性激活PKC/P38/NLRP3信号可减弱SB290157在脑出血后的抗炎作用。

证据类型、等级与局限

  • 证据类型:动物实验(小鼠脑出血模型)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,靶向C3aR抑制NLRP3依赖性神经炎症可能为脑出血治疗提供有前景的途径;该结论来自小鼠模型,尚未在临床人群中验证。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The C3a/C3aR axis has been shown to play an important role in a variety of neurological diseases. The aim of this study was to investigate the effects of the C3aR antagonist SB290157 on neuroinflammation in a mouse model of intracerebral hemorrhage (ICH) and the mechanism of the protein kinase C (PKC)/P38/NLRP3 signaling pathway in C3aR-mediated neuroinflammation.

METHODS: A total of 276 CD-1 mice were randomly assigned to different experimental groups. The ICH model was constructed by injecting autologous blood into the right basal ganglia, and SB290157 was administered intraperitoneally after 1 h. C3a (an endogenous ligand for C3aR), PMA (a specific PKC activator), and C3aR small interfering RNA (siRNA) were chosen to elucidate the underlying mechanisms. Western blots, immunofluorescence staining, Nissl staining, neurobehavioral tests, and brain water content tests were also performed.

RESULTS: C3aR was mainly expressed on microglia. The expression of C3a and C3aR was upregulated in the right hemisphere of the brain after ICH. Intraperitoneal injection of SB291057 improves short-term and long-term behavioral deficits, attenuates brain edema, and reduces the number of activated microglia and neutrophil infiltration after ICH and downregulates the expression of phosphorylated PKC, phosphorylated P38, and NLRP3, as well as tumor necrosis factor-α, interleukin-6 (IL-6), and IL-1β. Administration of C3aR siRNA and the C3aR endogenous agonist C3a reversed the protective effect of SB290157. In addition, selective activation of PKC/P38/NLRP3 signaling also attenuated the antiinflammatory effects of SB290157 after ICH.

CONCLUSIONS: This study demonstrates that SB290157 inhibits neuroinflammation and improves short-term and long-term neurological function after ICH in mice, at least in part through regulation of the C3aR/PKC/P38/NLRP3 signaling pathway. Targeting C3aR to inhibit NLRP3-dependent neuroinflammation may provide a promising therapeutic approach for treating ICH.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Qi D, Wei P, Cui Y, et al. Inhibition of C3a/C3aR by SB290157 Attenuates Neuroinflammation via PKC/P38/NLRP3 Signaling Pathway After Intracerebral Hemorrhage. Neurocrit Care. 2025. PMID: 40045037. doi:10.1007/s12028-025-02226-z

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。